Fundraise

Innovaccer crosses $200M ARR after $275M round, top-percentile among health raises

What's the deal? Innovaccer has raised $275 million in a late-stage round backed by B Capital, Danaher VenturesDealroom has a profile for this one. Try Dealroom →, Generation Investment ManagementDealroom has a profile for this one. Try Dealroom →, Kaiser PermanenteDealroom has a profile for this one. Try Dealroom →, and Microsoft's M12. The company, which unifies data locked inside hospitals' electronic health records and insurance claims systems, has now crossed $200 million in annual recurring revenue, up from roughly $130 million a year earlier.

Why now? US healthcare spending will top $6 trillion this year, and chief executive officer Abhinav Shashank estimates $1.5 trillion of it is pure administrative waste — forms, phone calls, and denied claims. He frames the opportunity bluntly: "Healthcare doesn't have internet," and without that layer, AI firms are "trying to put cars on a road that does not exist."

What's the endgame? Innovaccer pulls data from hospital records and claims systems, unifies it, and makes it usable for AI tools and care coordination. It works with seven of the top 10 US health systems across 80 million patient records, and has raised $675 million to date.

By the numbers: Customers reported roughly $2.5 billion in savings to federal regulators last year, mostly from care coordination rather than new hardware. Gartner named Innovaccer a leader in its first healthcare technology Magic Quadrant, ranking it above Microsoft, Google, AWS, and Salesforce on vision and execution.

The backstory: Shashank was 26 when he walked away from paying customers like Disney and NASA to bet his data analytics company on healthcare. He and his cofounders moved into Mercy Medical Center in Des Moines, Iowa, for four months, living inside the hospital's IT department to understand why doctors still ask every patient's name and date of birth. Word spread to hospitals in Nebraska, Texas, and California before the company had much of a sales team.

The signal: At $275 million, this ranks among the largest late-stage venture rounds ever recorded for an India-linked health company — the top percentile of 104 comparable deals. That scale of capital, paired with strategic backers like Kaiser Permanente and Danaher, signals investor conviction that healthcare's data plumbing, not flashy AI, is where the durable value sits.

Read more: fortune.com

More top stories